We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Serum Uric Acid Level Associated With Metabolic Syndrome

By LabMedica International staff writers
Posted on 27 Sep 2015
Metabolic syndrome (MetS) is defined by a cluster of risk factors, including obesity, dyslipidemia, hypertension, and insulin resistance, and when occurring together, they increase the risk of developing cardiovascular disease (CVD) and diabetes.

Serum uric acid is a final enzymatic product of purine metabolism in humans, and it is suggested that hyperuricemia is associated with MetS, and they may have common pathophysiology and in addition to MetS, elevated concentrations of uric acid are associated with a variety of cardiovascular conditions.

Scientists at Tehran University of Medical Sciences, (Iran) carried out a case-control study comprised 101 non-smoking individuals, 41 in the MetS group and 60 in the non-MetS group. Blood pressure, fasting plasma glucose, insulin, lipid profiles, uric acid, and anthropometric measures were determined, and body composition was assessed by using bioelectrical impedance analysis (BIA). Homeostasis Model Assessment (HOMA) was used for the assessment of insulin resistance.

Total cholesterol (TC) and TG were determined enzymatically using Parsazmun kits (Tehran, Iran). High density lipoprotein cholesterol (HDL-C) was measured similarly after precipitation with magnesium phosphotungstate. LDL-cholesterol was calculated using Friedewald’s formula. Fasting plasma glucose (FPG was measured using the glucose oxidase method, and immunoreactive insulin (IRI) was measured by radioimmunoassay.

After adjustment for confounding factors, serum uric acid was statistically significantly higher in MetS group at 5.70 ± 1.62 mg/dL than in non-MetS group 4.97 ± 1.30 mg/dL. Subjects in the MetS group had higher anthropometric and blood pressure measurements, body mass index (BMI), lean body mass (LBM), body fat mass (BFM), FPG, insulin, HOMA index, TG, TC, LDL, and lower HDL levels than the subjects in the non-MetS group.

The authors concluded that serum uric acid had independent association with MetS components, and increased the risk of MetS by nearly two-fold. The findings propose that uric acid can be considered as a component of MetS. The study was published on September 15, 2015, in the Journal of Diabetes & Metabolic Disorders.

Related Links:

Tehran University of Medical Sciences
Parsazmun



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Respiratory QC Panel
Assayed Respiratory Control Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.